Muhammad S. has extensive experience in oncology research and development, holding positions at Eli Lilly and Company and Agios Pharmaceuticals. At Eli Lilly, Muhammad served as Senior Director of Global Oncology R&D Strategy, where efforts were focused on advancing oncology trials and navigating pandemic-related challenges. Additionally, as Director of Asia-Pacific Clinical Development Operations, Muhammad enhanced enrollment efficiency for Trulicity® studies. Previous experience at Agios included optimizing preclinical studies for metabolic target drugs and advancing biomarker strategies for Tibsovo®. Muhammad holds a PhD in Oncology and Cancer Biology from the University of Massachusetts Amherst.
This person is not in the org chart
This person is not in any teams
This person is not in any offices